Senior care scores some wins in congressional budget deal
By
Alicia Lasek
Dec 21, 2022
A Congressional spending package for fiscal year 2023 supports key healthcare policy requests important to long-term care industry stakeholders, saving some clinicians and services from feared cuts.
Aduhelm’s costs: Medicare recipients won’t get premium reduction until 2023
By
Alicia Lasek (f3)
Jun 01, 2022
A cost overestimate that bumped up Medicare premiums for seniors in 2022 will not be corrected until the following year. The spike is tied to coverage for Alzheimer’s drug Aduhelm.
Eli Lilly expects Medicare about-face on Alzheimer’s drugs coverage
By
Alicia Lasek
Apr 23, 2023
New data on Lilly’s experimental drug donanemab may influence CMS’s restrictive stance on coverage of this and other amyloid-busting Alzheimer’s treatments, a company executive says.